TAM
REGN icon

Trust Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Trust Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Sell
1,127
-41
-4% -$27.9K 0.04% 123
2026
Q1 		$902K Hold
1,168
– – 0.06% 98
2025
Q4 		$902K Sell
1,168
-45
-4% -$30.6K 0.06% 98
2025
Q3 		$682K Hold
1,213
– – 0.05% 120
2025
Q2 		$637K Hold
1,213
– – 0.05% 125
2025
Q1 		$769K Sell
1,213
-24
-2% -$16.5K 0.06% 103
2024
Q4 		$881K Hold
1,237
– – 0.07% 99
2024
Q3 		$1.3M Hold
1,237
– – 0.1% 72
2024
Q2 		$1.3M Hold
1,237
– – 0.11% 70
2024
Q1 		$1.19M Hold
1,237
– – 0.1% 76
2023
Q4 		$1.09M Hold
1,237
– – 0.1% 76
2023
Q3 		$1.02M Hold
1,237
– – 0.11% 74
2023
Q2 		$889K Hold
1,237
– – 0.09% 83
2023
Q1 		$1.02M Buy
1,237
+18
+1% +$13.6K 0.11% 71
2022
Q4 		$879K Hold
1,219
– – 0.11% 78
2022
Q3 		$840K Buy
1,219
+95
+8% +$59.8K 0.11% 72
2022
Q2 		$664K Buy
1,124
+72
+7% +$46.8K 0.09% 86
2022
Q1 		$735K Buy
1,052
+48
+5% +$30.4K 0.09% 89
2021
Q4 		$634K Hold
1,004
– – 0.08% 98
2021
Q3 		$608K Buy
1,004
+68
+7% +$42.2K 0.08% 101
2021
Q2 		$523K Buy
936
+103
+12% +$52.2K 0.07% 102
2021
Q1 		$394K Buy
833
+150
+22% +$73K 0.05% 118
2020
Q4 		$330K Buy
683
+172
+34% +$92.8K 0.05% 112
2020
Q3 		$286K Buy
+511
New +$310K 0.05% 91

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Trust Asset Management's REGN Position: Q2 2026 in Review

Trust Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q2 2026, selling an estimated $27.9K and leaving 1,127 shares worth $703K. The position accounts for 0.04% of the portfolio, ranked #123.

Trust Asset Management first reported a position in REGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.3M in Q3 2024. 237 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Trust Asset Management held 1,127 shares of Regeneron Pharmaceuticals worth $703K as of Q2 2026.
  • Trust Asset Management sold 41 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
  • Regeneron Pharmaceuticals made up 0.04% of Trust Asset Management's portfolio in Q2 2026, its #123 holding.
  • Trust Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Trust Asset Management's Regeneron Pharmaceuticals position peaked at $1.3M in Q3 2024.
  • 237 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.